Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 299Lung Neoplasms 107Pancreatic Neoplasms 69Neoplasms 53Neoplasm Metastasis 31Brain Neoplasms 31Head and Neck Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Breast Neoplasms 25Glioblastoma 24Adenocarcinoma of Lung 23Gliosarcoma 22Non-Squamous Non-Small Cell Lung Cancer 18Colorectal Neoplasms 18Carcinoma, Hepatocellular 17Adenocarcinoma, Bronchiolo-Alveolar 16Rectal Neoplasms 13Colonic Neoplasms 13Carcinoma, Renal Cell 13Glioma 12Esophageal Neoplasms 11Astrocytoma 11Central Nervous System Neoplasms 9Carcinoma, Squamous Cell 9Salivary Gland Neoplasms 8Prostatic Neoplasms 8Oligodendroglioma 8Gallbladder Neoplasms 8Adenocarcinoma 8Ovarian Neoplasms 7

Interventions

Ultrasonography 2Tomography, X-Ray Computed 2tremelimumab 1lenvatinib 1hepatitis C immune globulin, human 1fluoromisonidazole 1epigallocatechin gallate 1durvalumab 1babao dan 1Vitamin B 6 1Urination 1Tomography 1Tidal Volume 1Rosuvastatin Calcium 1Propranolol 1Probiotics 1Preoperative Exercise 1Positron-Emission Tomography 1Portasystemic Shunt, Transjugular Intrahepatic 1Population Groups 1Plasmapheresis 1Oxaliplatin 1Nadolol 1Mebendazole 1Introns 1Immunoglobulin G 1Glutathione 1Gemcitabine 1Furosemide 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Cirrhosis × Erlotinib Hydrochloride × Clear all
NCT04172779 2026-05-01

ECHO-B

University of Texas Southwestern Medical Center

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡